David M Gershenson Selected Research

David M Gershenson Research Topics

Disease

98	Neoplasms (Cancer) 01/2022 - 01/2002
66	Carcinoma (Carcinomatosis) 01/2022 - 01/2002
54	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 05/2002
26	Ovarian Epithelial Carcinoma 11/2020 - 05/2002
16	Endometrial Neoplasms (Endometrial Cancer) 11/2020 - 05/2004
10	Disease Progression 11/2020 - 01/2005
7	Neoplasm Metastasis (Metastasis) 04/2009 - 01/2002
6	Neutropenia 11/2020 - 05/2002
6	Sex Cord-Gonadal Stromal Tumors (Sex Cord-Stromal Tumor) 05/2020 - 09/2004
5	Nausea 01/2022 - 05/2002
5	Anemia 11/2020 - 10/2002
4	Fatigue 01/2022 - 01/2008
3	Exanthema (Rash) 01/2022 - 04/2006
3	Granulosa Cell Tumor 01/2021 - 02/2004
3	Necrosis 04/2010 - 10/2006
3	Hypersensitivity (Allergy) 05/2009 - 09/2004
3	Vomiting 01/2008 - 05/2002
3	Thrombocytopenia (Thrombopenia) 05/2005 - 10/2002
2	Microsatellite Instability 01/2021 - 01/2004
2	Fallopian Tube Neoplasms 11/2020 - 01/2018
2	Diarrhea 11/2020 - 05/2002
2	Sarcoma (Soft Tissue Sarcoma) 11/2020 - 06/2005
2	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 05/2020 - 07/2007
2	Mucinous Adenocarcinoma (Mucinous Carcinoma) 12/2019 - 08/2010
2	Dysgerminoma 01/2018 - 06/2005
2	Teratoma (Teratoid Tumor) 01/2016 - 06/2005
2	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 08/2013 - 01/2006
2	Carcinogenesis 07/2013 - 02/2004
2	Genomic Instability 07/2013 - 07/2007
2	Febrile Neutropenia 06/2012 - 10/2002
2	Insulin Resistance 04/2011 - 06/2006

Drug/Important Bio-Agent (IBA)

33	PlatinumIBA 01/2022 - 05/2002
13	taxaneIBA 10/2020 - 05/2005
12	Proteins (Proteins, Gene)FDA Link 09/2013 - 09/2002
9	Docetaxel (Taxotere)FDA Link 07/2012 - 08/2006
8	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2005
8	Pharmaceutical PreparationsIBA 11/2020 - 05/2003
8	Carboplatin (JM8)FDA LinkGeneric 10/2020 - 01/2008
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2010 - 05/2004
7	Paclitaxel (Taxol)FDA LinkGeneric 10/2020 - 08/2004
6	Biological ProductsIBA 09/2015 - 10/2004
6	DNA (Deoxyribonucleic Acid)IBA 12/2014 - 09/2006
5	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 04/2004
5	Bevacizumab (Avastin)FDA Link 12/2019 - 12/2007
5	Phosphotransferases (Kinase)IBA 03/2015 - 08/2003
5	Imatinib Mesylate (Gleevec)FDA Link 06/2012 - 08/2003
5	LigandsIBA 04/2008 - 09/2002
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 12/2015
4	Cisplatin (Platino)FDA LinkGeneric 10/2020 - 05/2005
4	Small Interfering RNA (siRNA)IBA 05/2019 - 08/2006
4	Estrogen ReceptorsIBA 01/2018 - 10/2007
4	Cell-Free Nucleic AcidsIBA 04/2010 - 09/2006
4	Messenger RNA (mRNA)IBA 09/2009 - 07/2003
4	Proliferating Cell Nuclear Antigen (PCNA)IBA 08/2009 - 09/2006
4	Tyrosine (L-Tyrosine)FDA Link 09/2006 - 09/2002
4	Hormones (Hormone)IBA 01/2006 - 10/2002
3	Mitogen-Activated Protein KinasesIBA 01/2022 - 12/2015
3	Tumor Biomarkers (Tumor Markers)IBA 01/2021 - 05/2004
3	ErbB Receptors (EGF Receptor)IBA 11/2020 - 01/2007
3	Liposomes (Liposome)IBA 05/2019 - 08/2006
3	Focal Adhesion Protein-Tyrosine KinasesIBA 05/2019 - 10/2004
3	ParaffinIBA 12/2014 - 01/2002
3	Formaldehyde (Formol)FDA Link 12/2014 - 01/2002
3	Insulin-Like Growth Factor I (IGF-1)IBA 01/2013 - 05/2004
3	EnzymesIBA 12/2010 - 02/2006
3	Taxoids (Taxanes)IBA 01/2007 - 09/2004
3	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 04/2006 - 08/2003
3	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 06/2005 - 08/2003
3	Peptides (Polypeptides)IBA 11/2004 - 05/2002
2	Topotecan (Hycamtin)FDA LinkGeneric 11/2020 - 08/2009
2	Tyrosine Kinase InhibitorsIBA 11/2020 - 08/2003
2	RNA (Ribonucleic Acid)IBA 10/2020 - 07/2003
2	Transcription Factors (Transcription Factor)IBA 03/2017 - 06/2007
2	AZD 6244IBA 12/2015 - 02/2013
2	Everolimus FDA Link 03/2015 - 12/2010
2	Letrozole (Femara)FDA LinkGeneric 03/2015 - 07/2008
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 04/2014 - 10/2007
2	Eosine Yellowish-(YS) (Eosin)IBA 09/2013 - 11/2006
2	Hematoxylin (Haematoxylon)IBA 09/2013 - 11/2006
2	Estrogens (Estrogen)FDA Link 08/2013 - 04/2011
2	Insulin-Like Growth Factor Binding Protein 3IBA 07/2013 - 05/2004
2	TransferasesIBA 07/2013 - 01/2007
2	Indicators and Reagents (Reagents)IBA 06/2013 - 04/2004
2	Insulin-Like PeptidesIBA 10/2011 - 05/2004
2	Progesterone Receptors (Progesterone Receptor)IBA 12/2010 - 10/2007
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 12/2010 - 03/2007
2	TensinsIBA 12/2010 - 03/2007
2	CytokinesIBA 05/2009 - 05/2002
2	Platelet-Derived Growth FactorIBA 04/2008 - 04/2004
2	AEE 788 (AEE788)IBA 01/2007 - 10/2006

Therapy/Procedure

48	Therapeutics 01/2021 - 01/2002
36	Drug Therapy (Chemotherapy) 01/2022 - 10/2002
6	Lymph Node Excision (Lymph Node Dissection) 01/2019 - 10/2005
6	Hysterectomy 01/2017 - 04/2004
5	Cytoreduction Surgical Procedures 01/2019 - 07/2011
4	Salpingo-oophorectomy 03/2011 - 04/2004
3	Neoadjuvant Therapy 01/2020 - 03/2008
3	Adjuvant Chemotherapy 12/2019 - 04/2004
3	Drug Tapering 06/2012 - 04/2006
2	Aftercare (After-Treatment) 11/2020 - 04/2004